StonvexLoading…
StonvexStonvexStonvexCore line items from DAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $15.85B | $63.36B | $47.36B | $30.69B |
Operating Income | $501.00M | $5.82B | $4.36B | $2.67B |
Net Income | $-289.00M | $5.00B | $3.79B | $2.13B |
EPS (Diluted) | $-0.44 | $7.66 | $5.80 | $3.63 |
Total Assets | $84.43B | $81.32B | $79.62B | $78.39B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.05B | $4.31B | $3.79B | $3.33B |
Free Cash Flow OCF − CapEx | $1.23B | $3.84B | $2.49B | $1.80B |
Shares Outstanding | 652.00M | 654.00M | 653.00M | 652.00M |